Bentley InnoMed GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bentley InnoMed GmbH - overview
Established
2009
Location
-, -, Germany
Primary Industry
Medical Devices & Equipment
About
Based in Hechingen, Germany, and co-founded by Lars Sunnanväder and Miko Obradovic in 2009, Bentley Innomed GmbH operates as a medical devices and equipment manufacturing company specializing in vascular treatments. In October 2023, the firm’s minority stakes were acquired by a consortium led by Keensight Capital, including A. P. Moller Holding and Bonit Capital.
The firm as of November 2023, is led by its chairperson, Annika Sunnanväder, and its products are distributed in more than 80 countries. The international medical technology company is dedicated to the development, manufacturing, and marketing of products for minimally invasive vascular treatments. Some of the products offered by Bentley include BeGraft coronary for coronary intervention and BeGraft peripheral - first generation and second generation, BeSmooth peripheral, BeGraft aortic, BeGraft PLUS, etc for peripheral intervention. The October 2023 funding will support the company to expand its geographical footprint, reinforce its offering, and prepare for its incoming IPO process.
Current Investors
Keensight Capital, A.P. Moller Holding, Bonit Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Surgical Devices
Website
www.bentley.global/
Verticals
HealthTech
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Bentley InnoMed GmbH - timeline of key events
Bentley InnoMed GmbH - financials
| Fiscal Year Ended | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - | 7,399,772.1 | 10,264,512.6 | 12,254,546.9 | 12,401,491.1 | - | - | - |
| Operating Income (USD) | - | - | - | - | - | 6,977,832 | 9,602,512.8 | 11,199,402.3 | 11,394,084 | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (921,714.1) | (768,936.8) | 1,004,916.4 | 2,014,502 | - | 5,028,325.9 | 6,950,647 | 8,062,595.8 | 8,245,381.3 | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - | - | - |
Bentley InnoMed GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Bentley InnoMed GmbH | - |
Displaying 1 - 1 of 1
Bentley InnoMed GmbH - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.